The positive effect of JAK inhibitor tofacitinib in the treatment of primary Sjögren’s syndrome: a clinical case
Primary Sjögren’s syndrome (pSS, Sjögren’s disease) is a systemic autoimmune disease which develops in previously healthy individuals and characterized by damage to exocrine glands, mainly lacrimal and salivary glands, with gradual formation of their secretory insufficiency and various systemic mani...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2023-03-01
|
Series: | Bolʹ, Sustavy, Pozvonočnik |
Subjects: | |
Online Access: | https://pjs.zaslavsky.com.ua/index.php/journal/article/view/357 |